CRANFORD, N.J., Feb. 2, 2021 /PRNewswire/ -- Citius
Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a
specialty pharmaceutical company developing and commercializing
critical care drug products, will present at the upcoming Virtual
Investor Conferences Small and Microcap Showcase on Thursday, February 4, 2021. Citius Chairman of
the Board Leonard Mazur will present an update on the Company's
lead product candidate MinoLok, currently in Phase 3 trials, and an
overview of three other active programs.
Date: Thursday,
February 4, 2021
Time: 1:00 p.m. ET
Link: https://bit.ly/3brvZ8w
This will be a live, interactive online event where investors
are invited to ask the company questions in real-time. If attendees
are not able to join the event live on the day of the conference,
an archived webcast will also be made available after the event. It
is recommended that investors pre-register and run the online
system check to expedite participation and receive event
updates. Learn more about the event at
www.virtualinvestorconferences.com.
About Citius Pharmaceuticals, Inc.
Citius is a
late-stage specialty pharmaceutical company dedicated to the
development and commercialization of critical care products, with a
focus on anti-infectives and cancer care. For more information,
please visit www.citiuspharma.com.
Contact:
Andrew
Scott
Vice President, Corporate Development
(O) 908-967-6677 x105
(M) 646-522-8410
ascott@citiuspharma.com
View original
content:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-present-update-on-mino-lok-and-other-therapies-at-the-virtual-investor-conferences-small-and-microcap-showcase-on-february-4-301219900.html
SOURCE Citius Pharmaceuticals, Inc.